Lavelle Erin - Insider Trading & Ownership

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Lavelle Erin

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date		Reported
DateTime		Exercisable
Expiration		CompanySymnbolInsider
Relationship		Shares
Traded		Conversion
Price		Shares
Owned		Filing
2026-06-09
Option Award		2026-06-11
4:37 pm		N/A
2036-06-08		Jade Biosciences Inc.JBIOLavelle Erin
Director		34,843$034,843
(Direct)		View
2026-04-30
Option Award		2026-05-01
6:26 pm		N/A
2036-04-28		Avalyn Pharma Inc.AVLNLavelle Erin
Director		26,978$026,978
(Direct)		View

Ownership		2026-04-29
6:47 pm		N/A
2034-07-23		Avalyn Pharma Inc.AVLNLavelle Erin
Director		0$043,928
(Direct)		View
2025-04-29
Option Award		2025-05-01
6:15 pm		N/A
2035-04-29		Jade Biosciences Inc.JBIOLavelle Erin
Director		23,017$023,017
(Direct)		View

Ownership		2025-05-01
5:51 pm		N/A
2034-10-12		Jade Biosciences Inc.JBIOLavelle Erin
Director		0$0134,936
(Direct)		View
2023-06-08
Option Award		2023-06-09
4:25 pm		N/A
2033-06-07		Neoleukin Therapeutics Inc.NLTXLavelle Erin
Director		25,000$025,000
(Direct)		View
2022-10-31
Option Award		2022-11-02
7:08 pm		N/A
2032-10-30		Eliem Therapeutics Inc.ELYMLavelle Erin
COO & CFO		170,000$0170,000
(Direct)		View
2022-05-12
Option Award		2022-05-16
6:23 pm		N/A
2032-05-11		Neoleukin Therapeutics Inc.NLTXLavelle Erin
Director		25,000$025,000
(Direct)		View
2022-01-27
Option Award		2022-01-31
5:16 pm		N/A
2032-01-26		Eliem Therapeutics Inc.ELYMLavelle Erin
COO & CFO		170,000$0170,000
(Direct)		View